NEVER ALLOW A BABY TO SUFFER
JAUNDICE

14 million babies undergo
Inefficient JAUNDICE Treatment

Introducing 1st ever baby-centric phototherapy device
An Intelligent Phototherapy System

Globally, health care providers worldwide recognize that severe neonatal jaundice is a “silent” cause of significant neonatal morbidity and mortality.
OVER 60% OF ALL NEWBORNS DEVELOP NEONATAL JAUNDICE
AROUND 15% TO 45% OF NEWBORNS DEVELOP SEVERE NEONATAL JAUNDICE IN DEVELOPING COUNTRIES
AROUND 10% OF NEWBORNS DIE DUE TO NEONATAL JAUNDICE ALL OVER THE WORLD
ALMOST 20% OF THE JAUNDICE BABIES IN INDIA ALONE ,DIE DUE TO SEVERE NEONATAL JAUNDICE
Methods used currently Delay the treatment to 2-3 weeks. Our goal is to reduce the treatment time significantly
Blood transfusion is a miserable solution for severe jaundice cases. Hence, current indigenous methods of maneuvering with multiple devices are not addressing the need.
Just after birth separation of her baby lead to Anxiety and accelerates the postnatal trauma. whereas on the other hand, the newborn loses the advantage of initial bond with its mother.
The efficiency of the treatment is directly proportional to optimum irradiance, Exposure of Baby Body Surface Area, and sufficient Hydration via Breastfeeding.
Introducing A smart Design approached technology
A Revolutionary Phototherapy device for neonatal jaundice management.
The SMART algorithm adds efficiency and helps to reduce prolonged treatment time
Our Human Centric Design approach prioritizes Needs of the Newborn in First Place.
Robust design and transformable mechanism support to handle critical conditions in low- resource settings.
A flexible design which promotes breastfeeding and Kangaroo Mother Care.
Our Design embraces the baby from 360° which enhances Billurubin disintegration
HEAMAC has been featured in…